Trefoil Factor Family: Unresolved Questions and Clinical Perspectives
- PMID: 30792027
- PMCID: PMC6557713
- DOI: 10.1016/j.tibs.2019.01.004
Trefoil Factor Family: Unresolved Questions and Clinical Perspectives
Abstract
The trefoil factor family of peptides (TFF1, TFF2, TFF3) with their lectin activities play important roles in mucosal protection and repair. However, major gaps in understanding their molecular function have hampered therapeutic development for gastrointestinal disorders. We provide here a critical overview of the status quo.
Keywords: cell migration; gastrointestinal wound healing; lectin; mucins; mucosal protection; mucositis.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Figures
References
-
- Hoffmann W. TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more. Int J Oncol. 2015;47:806–816. - PubMed
-
- Roa B, Tortolero S. Trefoil factor 3 (TFF3) from human breast milk activates PAR-2 receptors, of the intestinal epithelial cells HT-29, regulating cytokines and defensins. Bratisl Med J. 2016;117:332–339. - PubMed
-
- Hoffmann W. Trefoil Factor Family (TFF) peptides and chemokine receptors: a promising relationship. J Med Chem. 2009;52:6505–6510. - PubMed
-
- Peterso DE, et al. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. J Clin Oncol. 2009;27:4333–4338. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
